Key terms

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NVAX news

Yesterday 9:35pm ET Upcoming Deadline to Share in Novavax, Inc. (NVAX) Class Action Settlement Mar 26 4:07pm ET Novavax discloses confidential settlement agreement with Fujifilm Mar 19 12:19am ET Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era Mar 11 9:10am ET Novavax notes Canada’s National Advisory Committee on Immunization guidance Mar 01 6:25am ET Novavax price target lowered to $19 from $35 at H.C. Wainwright Feb 29 11:25am ET Novavax call volume above normal and directionally bullish Feb 29 8:16am ET Optimistic Outlook for Novavax: Strategic Plans and Financial Health Signal Market Share Growth Potential Feb 28 9:55pm ET Maintaining Hold on Novavax: Assessing Current Performance and Future Market Penetration Strategies Feb 28 3:58pm ET Novavax says CDC advisors in favor of added COVID vaccine dose for 65 and older Feb 28 8:04am ET Novavax sees FY24 revenue $800M-$1.000B, consensus $969.56M Feb 28 8:02am ET Novavax reports Q4 EPS ($1.44), consensus (45c) Feb 26 12:05pm ET Novavax call volume above normal and directionally bullish Feb 23 8:30am ET Novavax price target lowered to $11 from $12 at B. Riley Feb 22 3:09pm ET Novavax (NASDAQ:NVAX) Settles, Shares Blast Up Feb 22 1:26pm ET Optimizing for Growth: Novavax’s Settlement, Cost Reductions, and CIC Vaccine Propel Buy Rating Feb 22 9:40am ET Unusually active option classes on open February 22nd Feb 22 6:32am ET Novavax to pay $80M annually to Gavi in settlement for COVID-19 vaccine APA Feb 22 6:26am ET Novavax Settles with Gavi, Commits to Equitable Vaccine Pricing Feb 03 5:07pm ET Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal Feb 02 8:40am ET Novavax announces results from Phase 3 trial of R21/Matrix-M malaria Feb 01 12:52am ET Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Align Tech (ALGN) and Novavax (NVAX) Jan 31 8:27am ET Novavax to reduce current total global workforce by about 12% Jan 17 8:45am ET Largest borrow rate increases among liquid names Jan 02 1:25pm ET Novavax call volume above normal and directionally bullish

No recent press releases are available for NVAX

NVAX Financials

1-year income & revenue

Key terms

NVAX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NVAX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms